DMCC Speciality Chemicals Ltd (DMCC)
🎯 Key Takeaways
- DMCC Speciality Chemicals is in a strategic transition phase, shifting from bulk to specialty chemicals to achieve higher-margin profile and reclassification as a true specialty player by FY27-FY28. Management is executing capacity expansion at Dahej and increasing R&D spend, but progress is constrained by sulfur supply disruptions and pending land monetization despite favorable court rulings.
- Revenue grew 42.4% QoQ to ₹253 in Q1FY27.
- ⚠️ 1) Persistent sulfur supply constraints from Middle East imports continue to limit Roha plant capacity utilization, directly impacting production and
- Market Cap
- ₹756
- P/E Ratio
- 18.9
- P/B Ratio
- 3.05
- ROE
- 16.1%
- ROCE
- 19.8%
- Debt/Equity
- 0.35
- Div Yield
- 0.82%
- Promoter
- 53.8%
📖 The Story
DMCC Speciality Chemicals is in a strategic transition phase, shifting from bulk to specialty chemicals to achieve higher-margin profile and reclassification as a true specialty player by FY27-FY28. Management is executing capacity expansion at Dahej and increasing R&D spend, but progress is constrained by sulfur supply disruptions and pending land monetization despite favorable court rulings.
📰 What's Happening
In Q4 FY26 (ended March 2026), revenue reached ₹253 crores with operating profit of ₹30 crores, up from ₹178 crores and ₹14 crores respectively in Q3 FY26, reflecting partial recovery despite sulfur-related operational strain. Management highlighted that the European revenue decline was offset by growth in Latin America and Asia, while the Boron business showed signs of recovery. The company continues to target gross margins above 50% for specialty products, though commercialization timelines remain unconfirmed. A board-approved dividend of ₹2.5 per share (25% yield) was declared, with payment contingent on AGM approval on September 11, 2026.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 126 | 151 | 178 | 253 |
| Operating Profit | 10 | 11 | 14 | 30 |
| OPM % | 7.8% | 7.3% | 7.9% | 12.0% |
| Net Profit | 6 | 6 | 8 | 20 |
| EPS | ₹2.31 | ₹2.47 | ₹3.07 | ₹8.18 |
Revenue and operating profit show sequential improvement from ₹126 crores and ₹10 crores in September 2025 to ₹253 crores and ₹30 crores in June 2026, indicating recovery momentum. However, gross margins remain near 40% and are targeted to exceed 50% for specialty products, with commercialization timelines still unspecified. Working capital expansion due to higher raw material costs and longer receivables suggests ongoing investment in operations, while sulfur inventory of ₹92 crores covers only 15-20 days of supply amid import constraints.
🔮 Management Outlook & What's Next
Management has not provided formal forward guidance on revenue growth or margin targets beyond the strategic objective of reclassifying as a true specialty player by FY27-FY28. They have emphasized capacity expansion at Dahej, increased R&D beyond ₹2 crores annually, and the importance of geographic diversification to offset European softness. No specific financial targets or timelines for margin improvement were disclosed in the latest filings.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 |
| Reserves | 203 | 188 | 223 | 209 |
| Borrowings | 47 | 60 | 87 | 40 |
| Total Liabilities | 380 | 389 | 446 | 375 |
| Fixed Assets | 234 | 218 | 200 | 207 |
| Investments | 0 | 0 | 1 | 1 |
| Total Assets | 380 | 389 | 446 | 375 |
The balance sheet shows stable equity of ₹25 crores with reserves growing from ₹203 crores to ₹223 crores, while borrowings declined from ₹47 crores to ₹87 crores in consolidated terms, indicating a modest reduction in leverage. Total assets rose to ₹446 crores, suggesting ongoing capital investment. The company maintains a low debt-to-equity ratio of 0.21, supporting financial flexibility, though working capital pressures from raw material costs and receivables remain a concern.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +38 |
| Investing | -7 |
| Financing | -30 |
| Net Cash Flow | +2 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 53.8% | 53.8% | 53.8% | 53.8% |
| FII | 0.4% | 0.1% | 0.1% | 0.1% |
| DII | 1.3% | 1.3% | 1.3% | 1.5% |
| Public | 34.5% | 33.3% | 33.0% | 32.9% |
| # Shareholders | 22,015 | 18,552 | 18,175 | 18,906 |
Promoter holding remains stable at 53.84% across all quarters, but FII ownership has declined sharply from 0.39% in Q2FY26 to 0.15% in Q1FY27, while DII increased slightly from 1.27% to 1.5%. Public shareholding rose from 33.03% to 32.85%, with the number of shareholders increasing to 18,906. The decline in FII participation may reflect reduced institutional confidence or portfolio rebalancing, despite stable promoter stakes.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Persistent sulfur supply constraints from Middle East imports continue to limit Roha plant capacity utilization, directly impacting production and margins. 2) Pending land monetization, despite a favorable Supreme Court ruling, remains unresolved and could affect capital allocation and growth plans. 3) Commercialization timelines and margin targets for specialty products are unconfirmed, creating uncertainty around long-term profitability improvements. 4) Declining FII ownership (from 0.39% to 0.15%) may signal weakening institutional interest amid sectoral headwinds.
📋 Recent Filings
- Announcement2026-09-24DMCC Speciality Chemicals announced the closure of its trading window effective October 1, 2026, until 48 hours after the board meeting to approve una…
- 🟡 voting results2026-09-11DMCC Speciality Chemicals held its 105th AGM on September 11, 2026 via video conferencing. All 8 resolutions were passed with requisite majority. Shar…
- 🟡 Board Meeting2026-09-11DMCC Speciality Chemicals held its 105th AGM on September 11, 2026 via video conference, with 57 shareholders present. All directors, key managerial p…
- 🔴 annual report2026-09-10DMCC Speciality Chemicals issued a corrigendum to its 105th Annual Report for FY 2025-26, correcting a typographical error on page 21 where R&D invest…
- 🔴 annual report2026-08-18DMCC Speciality Chemicals announced its 105th Annual General Meeting will be held on September 11, 2026 at 11:30 a.m. IST via video conference, with t…
- Announcement2026-08-13DMCC Speciality Chemicals reported Q1FY27 revenue of [amount context mismatch] crore, up 2.8% year-on-year, with profit after tax surging 166.58% to ₹…
- 🟡 Board Meeting2026-08-10DMCC Speciality Chemicals announced the outcome of its August 10, 2026 board meeting, approving unaudited standalone and consolidated financial result…
- 🔴 Corporate Action2026-08-10DMCC Speciality Chemicals announced a dividend of Rs 2.5 per share (25% yield) with record date August 21, 2026, and payment within 30 days of AGM app…
- share transfer2026-07-07DMCC Speciality Chemicals Limited received a SEBI-mandated share transfer agent certificate for the quarter ended June 30, 2026, confirming dematerial…
- Announcement2026-06-26DMCC Speciality Chemicals clarified that a recent spike in trading volume across exchanges is purely market-driven with no undisclosed price-sensitive…
🧠 Analyst's Read
DMCC Speciality Chemicals is navigating a strategic pivot toward specialty chemicals amid operational and supply chain challenges. The trajectory hinges on resolving sulfur supply issues, executing land monetization, and achieving margin expansion in specialty segments — key watchpoints for the next 6-12 months.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DMCC files new disclosures
Track DMCC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DMCC — FreeFree account · 2 AI queries/day